Puneet Souda
Stock Analyst at Leerink Partners
(1.95)
# 2,963
Out of 4,734 analysts
215
Total ratings
45.66%
Success rate
-0.86%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $12.39 | +69.49% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $2.98 | +34.23% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $40.58 | -1.43% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $158.36 | -5.28% | 7 | Oct 17, 2024 | |
| HOLX Hologic | Maintains: Outperform | $95 → $90 | $69.73 | +29.07% | 6 | Oct 8, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $404.00 | -7.18% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.50 | +33.33% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $559.65 | +12.57% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $24.94 | +40.34% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $147.36 | -1.60% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $238.36 | +25.86% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $136.67 | +82.92% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $75.83 | +45.06% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $51.74 | +44.96% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $160.51 | +24.60% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.97 | +506.06% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $3.21 | +86.92% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $47.56 | -36.92% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $8.87 | +69.11% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $14.21 | +5.56% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $56.88 | +52.95% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $36.66 | +281.89% | 5 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20,000 → $15,000 | $0.26 | +5,769,130.77% | 5 | Jan 27, 2021 |
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $12.39
Upside: +69.49%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $2.98
Upside: +34.23%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $40.58
Upside: -1.43%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $158.36
Upside: -5.28%
Hologic
Oct 8, 2024
Maintains: Outperform
Price Target: $95 → $90
Current: $69.73
Upside: +29.07%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $404.00
Upside: -7.18%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.50
Upside: +33.33%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $559.65
Upside: +12.57%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $24.94
Upside: +40.34%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $147.36
Upside: -1.60%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $238.36
Upside: +25.86%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $136.67
Upside: +82.92%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $75.83
Upside: +45.06%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $51.74
Upside: +44.96%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $160.51
Upside: +24.60%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.97
Upside: +506.06%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $3.21
Upside: +86.92%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $47.56
Upside: -36.92%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $8.87
Upside: +69.11%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $14.21
Upside: +5.56%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $56.88
Upside: +52.95%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $36.66
Upside: +281.89%
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $0.26
Upside: +5,769,130.77%